16.45

1.67% -0.28

Certara Inc (CERT)

Overview News Price History Option Chain Discussions Forecast

Certara Inc stock is currently priced at $16.45, with a 24-hour trading volume of 406.96K. It has seen a -1.67% decreased in the last 24 hours and a -5.19% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $16.61 pivot point. If it approaches the $16.31 support level, significant changes may occur.

Previous Close:

$16.73

Open:

$16.64

24h Volume:

406.96K

Market Cap:

$2.64B

Revenue:

$354.34M

Net Income/Loss:

$-55.36M

P/E Ratio:

137.08

EPS:

0.12

Net Cash Flow:

$67.43M

1W Performance:

-2.95%

1M Performance:

-5.19%

6M Performance:

+22.30%

1Y Performance:

-32.39%

1D Range:

$16.32

$16.74

52W Range:

$11.81

$24.70

Certara Inc Stock (CERT) Company Profile

Name

Certara Inc

Sector

Healthcare (1198)

Industry

Health Information Services (61)

Phone

609-716-7900

Address

100 Overlook Center, Suite 101, Princeton

Employee

Twitter

Next Earnings Date

2024-05-21

Latest SEC Filings

CERT's Discussions on Twitter

Certara Inc Stock (CERT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-07-23	Initiated	UBS	Neutral
Dec-05-23	Initiated	KeyBanc Capital Markets	Sector Weight
Aug-22-23	Downgrade	Jefferies	Buy → Hold
Aug-10-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-12-23	Initiated	Stephens	Overweight
Apr-03-23	Downgrade	Barclays	Overweight → Equal Weight
Dec-14-22	Downgrade	Robert W. Baird	Outperform → Neutral
Sep-08-22	Initiated	Berenberg	Buy
Aug-25-22	Initiated	Credit Suisse	Outperform
Jul-01-22	Initiated	Piper Sandler	Overweight
Jan-11-22	Upgrade	Jefferies	Hold → Buy
Aug-05-21	Resumed	Credit Suisse	Neutral
Jul-23-21	Initiated	Robert W. Baird	Outperform
Mar-03-21	Initiated	Barclays	Overweight
Jan-06-21	Initiated	Morgan Stanley	Equal-Weight
Jan-05-21	Initiated	BofA Securities	Buy
Jan-05-21	Initiated	Credit Suisse	Neutral
Jan-05-21	Initiated	Jefferies	Hold
Jan-05-21	Initiated	William Blair	Outperform

View All

Certara Inc Stock (CERT) Latest News

Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference

GlobeNewswire Inc.

Certara Inc Stock (CERT) Financials Data

Certara Inc (CERT) Revenue 2024

CERT reported a revenue (TTM) of $354.34 million for the quarter ending December 31, 2023, a +5.57% rise year-over-year.

Certara Inc (CERT) Net Income 2024

CERT net income (TTM) was -$55.36 million for the quarter ending December 31, 2023, a -475.79% decrease year-over-year.

Certara Inc (CERT) Cash Flow 2024

CERT recorded a free cash flow (TTM) of $67.43 million for the quarter ending December 31, 2023, a -15.72% decrease year-over-year.

Certara Inc (CERT) Earnings per Share 2024

CERT earnings per share (TTM) was -$0.35 for the quarter ending December 31, 2023, a -506.03% decline year-over-year.

Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies and academic institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.